We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+40.55%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.47B
AUM Growth
+$207M
Cap. Flow
-$137M
Cap. Flow %
-9.32%
Top 10 Hldgs %
9.07%
Holding
898
New
262
Increased
152
Reduced
230
Closed
245

Top Buys

Rank Stock Value
1
BE icon
Bloom Energy
BE
+$9.29M
2
ZEN
ZENDESK INC
ZEN
+$9.24M
3
NTAP icon
NetApp
NTAP
+$8.82M
4
BFAM icon
Bright Horizons
BFAM
+$8.68M
5
LLY icon
Eli Lilly
LLY
+$8.53M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$31.8M
2
HUM icon
Humana
HUM
+$24.8M
3
EOG icon
EOG Resources
EOG
+$17.3M
4
DINO icon
HF Sinclair
DINO
+$9.96M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.7M

Sector Composition

Rank Sector Weight
1 Technology 23.74%
2 Healthcare 23.44%
3 Consumer Discretionary 13.66%
4 Industrials 10.93%
5 Financials 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KURA icon
601
Kura Oncology
KURA
$826M
$185K 0.01%
11,334
-43,067
-79% -$621K
PGTI
602
DELISTED
PGT, Inc.
PGTI
$185K 0.01%
+11,814
New +$142K
PRA
603
DELISTED
ProAssurance
PRA
$184K 0.01%
+12,712
New +$218K
AMAL icon
604
Amalgamated Financial
AMAL
$1.49B
$182K 0.01%
14,360
+3,660
+34% +$38.8K
OSBC icon
605
Old Second Bancorp
OSBC
$1.3B
$166K 0.01%
21,400
+6,346
+42% +$47K
TILE icon
606
Interface
TILE
$2B
$166K 0.01%
+20,400
New +$173K
CBIO
607
Crescent Biopharma
CBIO
$608M
$158K 0.01%
419
CARE icon
608
Carter Bankshares
CARE
$768M
$151K 0.01%
+18,688
New +$150K
NOA
609
North American Construction
NOA
$370M
$148K 0.01%
23,600
-5,441
-19% -$30.7K
ACIU icon
610
AC Immune
ACIU
$236M
$144K 0.01%
+21,413
New +$156K
CABA icon
611
Cabaletta Bio
CABA
$445M
$142K 0.01%
+12,745
New +$97.6K
RYZ
612
Ryerson Holding Corp
RYZ
$1.61B
$142K 0.01%
25,200
+14,322
+132% +$70.8K
GTES icon
613
Gates Industrial Corporation Ltd.
GTES
$6.69B
$141K 0.01%
13,670
-1,897
-12% -$17.2K
QTNT
614
DELISTED
Quotient Limited Ordinary Shares
QTNT
$138K 0.01%
+467
New +$134K
NOV icon
615
NOV
NOV
$7.11B
$137K 0.01%
11,187
-97,941
-90% -$1.2M
BV icon
616
BrightView Holdings
BV
$1.3B
$134K 0.01%
+11,966
New +$145K
MX icon
617
Magnachip Semiconductor
MX
$118M
$133K 0.01%
12,915
-43,420
-77% -$484K
MTUS icon
618
Metallus
MTUS
$879M
$131K 0.01%
33,631
-5,296
-14% -$17.7K
GYRE icon
619
Gyre Therapeutics
GYRE
$668M
$129K 0.01%
2,920
-273
-9% -$12.8K
BDSI
620
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$128K 0.01%
29,468
-3,032
-9% -$13.6K
SLDB icon
621
Solid Biosciences
SLDB
$785M
$127K 0.01%
2,887
-3,912
-58% -$162K
SPPI
622
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$127K 0.01%
37,600
-88,800
-70% -$259K
DVN icon
623
Devon Energy
DVN
$49.2B
$121K 0.01%
+10,699
New +$122K
NVGS icon
624
Navigator Holdings
NVGS
$1.34B
$121K 0.01%
18,879
+4,379
+30% +$27.5K
VISN
625
Vistance Networks Inc
VISN
$2.67B
$116K 0.01%
+13,970
New +$138K

Similar funds

PDT Partners's Q2 2020 Portfolio in Review

As of Q2 2020, PDT Partners held 898 positions worth $1.47B, up 16% from $1.26B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

PDT Partners withdrew a net $137M in Q2 2020, closing 245 positions and reducing 230 holdings. Its most notable exit was AbbVie, an estimated $31.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in ZENDESK INC worth $10.6M.

  • PDT Partners's largest Q2 2020 buy was ZENDESK INC: 119,997 shares worth $10.6M.
  • PDT Partners added most to Bloom Energy in Q2 2020, an estimated $9.29M increase.
  • PDT Partners's biggest Q2 2020 reduction was EOG Resources, cutting an estimated $17.3M.
  • PDT Partners fully exited AbbVie in Q2 2020, selling an estimated $31.8M.
  • PDT Partners's ten largest holdings make up 9.1% of its $1.47B portfolio in Q2 2020.
  • PDT Partners opened 262 new positions and closed 245 in Q2 2020.
  • PDT Partners's portfolio value rose 16% quarter-over-quarter to $1.47B.

Based on PDT Partners's 13F filing for Q2 2020, filed 14 Aug 2020.